FLT3 and acute myeloid leukemia: Based on the essential binding mode of Type II FLT3 inhibitors with FLT3, we designed and synthesized a novel FLT3 inhibitor, 5-3, which derived from the unique structure of plinabulin and exhibited selective inhibition on FLT3-ITD mutant AML cells.